OpGen, Inc. (OPGN)
OTCMKTS · Delayed Price · Currency is USD
24.00
-0.50 (-2.04%)
Mar 2, 2026, 3:50 PM EST
OpGen Market Cap
OpGen has a market cap or net worth of $292.28 million as of March 2, 2026. Its market cap has increased by 2,020.02% in one year.
Market Cap
292.28M
Enterprise Value
293.76M
Revenue
9.00M
Ranking
n/a
PE Ratio
63.82
Stock Price
$24.00
Market Cap Chart
Since May 5, 2015, OpGen's market cap has increased from 51.90M to 292.28M, an increase of 463.21%. That is a compound annual growth rate of 17.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 298.37M | 84.89% |
| Dec 31, 2025 | 161.38M | 2,593.85% |
| Dec 31, 2024 | 5.99M | 42.44% |
| Dec 29, 2023 | 4.21M | -44.45% |
| Dec 30, 2022 | 7.57M | -80.56% |
| Dec 31, 2021 | 38.95M | -15.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tian'an Technology Group | 182.07M |
| Zomedica | 128.57M |
| Positron | 82.07M |
| RetinalGenix Technologies | 59.54M |
| Family Office of America | 59.00M |
| CS Diagnostics | 46.25M |
| Vivos | 38.68M |
| Guided Therapeutics | 32.08M |